Well...how about NEVER!
3% less deaths and hospital stay cut by a 3rd is not a big deal.
It is not a trivial thing to make it chemically. There is a number of asymmetric centers in the molecule defining it’s exact spatial structure and making chemistry and overall final purity complicated. This probably explains, in part, the high cost of remdesivir.
...Steps to produce the drug in India
First, Gilead will have to give its approval for Indian companies to manufacture the drug, which will most likely be in the form of a voluntary licencing arrangement, under which it will transfer technology.
An industry insider... explained: After signing the agreement, Gilead will transfer the technology through which Indian companies will start producing the active pharmaceutical ingredients (APIs). These APIs will then be converted into injectable formulations.
*************************************************************
Build up AMERICAN capabilities to produce the AMERICAN DEVELOPED drug commercially. We need robust pharmaceutical manufacturing infrastructure HERE in OUR COUNTRY. Havent we learned the downside of technology transfers and moving production capabilities to foreign Nations by now?
Who owns the patents?
And here we see the difference between China and honest countries. India is talking about licensing the manufacture from the company that developed it. China is trying to steal it.
I read that CCP holds the patent on Remdesivir and that Soros and gates are major contributors to Gilead development, not to mention shorty, Dr. Fauci.
I read that CCP holds the patent on Remdesivir and that Soros and gates are major contributors to Gilead development, not to mention shorty, Dr. Fauci.